In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...
Expanded indication makes Omnipod the first automated insulin delivery system to be approved for the management of both type 1 and type 2 diabetes. The FDA has cleared Insulet Corporation’s Omnipod 5 ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's PODD Omnipod 5 Pods as its most ...
Insulet Presents Pivotal Extension Data for Preschool Children and Other Omnipod® 5 System Clinical Research at American Diabetes Association 82nd Scientific Sessions ACTON, Mass.--(BUSINESS WIRE)-- ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Insulet enrolled the first participant in a study of its fully closed-loop automated insulin delivery system for type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results